Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
•Expert Board Member of EU Commission study on the economic impact of pharma incentives
Minssen, Timo (Consultant)
Apr 2017 → Jan 2018Activity: Consultancy types › Consultancy
“Should we change EU law to disallow DNA patents?”: 2016 Philomathia Symposium- University of Cambridge
Minssen, Timo (Invited speaker)
18 Nov 2016Activity: Talk or presentation types › Lecture and oral contribution
“Konferens om kommersialisering av immaterialrätter”
Minssen, Timo (Participant)
19 Mar 2008Activity: Participating in an event - types › Participation in workshop, seminar, course
“Early Publishing of Clinical Trial Data, Striking the Balance between Patent Protection & the Wider Public Interest”: C5 Life Science IP Summit 2016 in London
Minssen, Timo (Panel member)
20 Oct 2016Activity: Talk or presentation types › Lecture and oral contribution
“AI in the Medical Sciences & the Lex Machina”
Minssen, Timo (Invited speaker)
20 Nov 2018Activity: Talk or presentation types › Lecture and oral contribution
the 4th Open Call - Study on the application of FAIR principles across and within different EU jurisdictions
Minssen, Timo (Consultant)
2020Activity: Consultancy types › Consultancy
microRNA and other ncRNAs in health and disease
Minssen, Timo (Participant)
7 Nov 2012Activity: Participating in an event - types › Organisation of and participation in conference
XXIX NIR- möte & Centennial Celebration, Stockholm. Conference and 100 year celebration of the SFIR and the Swedish AIPPI group
Minssen, Timo (Participant)
24 Aug 2008 → 27 Aug 2008Activity: Participating in an event - types › Participation in workshop, seminar, course
World Health Organization (External organisation)
Minssen, Timo (Member)
2021 → …Activity: Membership types › Membership in committee, council, board
World Health Organization (External organisation)
Minssen, Timo (Member)
2021Activity: Membership types › Membership in committee, council, board
ID: 16150437
Most downloads
-
4329
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2187
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2078
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published